Specialized ambulatory palliative care for urological tumors

被引：0

作者：

Degener, Stephan ^{[1
]}

Dreger, Nici Markus ^{[1
]}

von Rundstedt, Friedrich-Carl ^{[1
]}

Schmitz, Marie-Therese ^{[2
]}

Grabenhorst, Ulrich ^{[3
]}

Schmalz, Oliver ^{[4
]}

Weckbecker, Klaus ^{[5
]}

Just, Johannes ^{[5
]}

机构：

[1] Univ Witten Herdecke, Klin Urol & Kinderurol, Helios Univ Klinikum Wuppertal, Heusnerstr 40, D-42283 Wuppertal, Germany

[2] Univ Bonn, Inst Med Biometrie Informat & Epidemiol IMBIE, Med Fak, Bonn, Germany

[3] Verbund SAPV Teams Nordrhein e V, Solingen, Germany

[4] Univ Witten Herdecke, Helios Univ Klinikum Wuppertal, Klin Hamatol Onkol Klin Infektiol & Palliativmediz, Wuppertal, Germany

[5] Univ Witten Herdecke, Inst Allgemeinmed & Ambulante Gesundheitsversorgun, Witten, Germany

来源：

UROLOGIE | 2025年 / 64卷 / 08期

关键词：

Krebs; Palliativmedizin; Symptommanagement; SAPV; Pflege am Lebensende; Cancer; Palliative care; Symptom management; End-of-life care; DEATH CERTIFICATES; ADVANCED CANCER; LIFE; END; TRENDS; PLACE;

D O I：

10.1007/s00120-025-02573-x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

BackgroundUrologic tumors comprise about 20% of cancer diagnoses in Germany. To date, there are no studies with large datasets on the palliative situation of patients with urological tumors in the home environment, although dignified end-of-life care in the home environment is the wish of most cancer patients. MethodsData from 5125 patients who received specialized outpatient palliative care (SAPV) with an underlying urological cancer between 2017 and 2021 were included in the analysis. ResultThe analysis showed that 91.5% of patients died at home and the symptom burden remained stable or decreased slightly during treatment. The median survival time of patients receiving SAPV was 24 days. Factors such as age, performance status, loss of appetite, weakness, and pain at the start of treatment influenced the survival time of the patients. Relatives were largely very satisfied with the care provided. ConclusionThe study provides important insights into the palliative care of patients with urological tumors and underlines the importance of SAPV for dignified end-of-life care.

引用

页码：784 / 792

页数：9

共 19 条

[1]

[Anonymous], 2023, BEVOLKERUNG NACH GEM

[2]

Caglayan Aydin, 2023, Ann Palliat Med, V12, P1373, DOI 10.21037/apm-22-1154

[3] VALIDATION OF A COMBINED COMORBIDITY INDEX [J].

CHARLSON, M ;

SZATROWSKI, TP ;

PETERSON, J ;

GOLD, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251

[4] Place of Death Trends and Utilization of Outpatient Palliative Care at the End of Life Analysis of Death Certificates (2001,2011,2017) and Pseudonymized Data From Selected Palliative Medicine Consultation Services (2017) in Westphalia, Germany [J].

Dasch, Burkhard ;

Zahn, Peter K. .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2021, 118 (19-20) :331-+

[5] Place of Death: Trends Over the Course of a Decade A Population-Based Study of Death Certificates From the Years 2001 and 2011 [J].

Dasch, Burkhard ;

Blum, Klaus ;

Gude, Philipp ;

Bausewein, Claudia .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (29-30) :496-504

[6] Palliative care at the end of life in Germany Utilization and regional distribution [J].

Ditscheid, Bianka ;

Krause, Markus ;

Lehmann, Thomas ;

Stichling, Kathleen ;

Jansky, Maximiliane ;

Nauck, Friedemann ;

Wedding, Ulrich ;

Schneider, Werner ;

Marschall, Ursula ;

Meissner, Winfried ;

Freytag, Antje .

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2020, 63 (12) :1502-1510

[7] Palliative care guidelines in uro-oncology [J].

Engel, K. ;

Kirschner, P. ;

Allrich, T. ;

Draeger, D. L. ;

Protzel, C. .

UROLOGE, 2022, 61 (03) :273-281

[8]

Geist MJP, 2018, UROLOGE, V57, P563, DOI 10.1007/s00120-018-0571-0

[9]

Geist M JP., 2018, Zeitschrift fur Palliativmedizin, V19, P149, DOI DOI 10.1055/S-0043-124478

[10] Urology at the end of life - the urologist as a palliative care physician [J].

Gleissner, J. .

UROLOGE, 2015, 54 (09) :1234-+

← 1 2 →